Life Science Technology

Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them to find—relatively quickly and cheaply—antibodies that have a desired effect on cells. The TSRI scientists used the technique to discover two antibodies that protect human cells from a cold virus.

In a 2012 report, Global Industry Analysts in San Jose, California forecast a growing market for carbon dioxide (CO2) incubators. That comes as no surprise given this technology’s laundry list of applicable fields, which includes cell and tissue culture, protein synthesis, and much more.

CO2 incubators are designed to copy a cell’s natural environment with a relative humidity of around 95 percent, a temperature of 37°C and a pH of 7.2 to 7.5. They are most common in biology labs performing tissue or cell culture and are used in any process where cells need to be cultured for a few hours or many weeks or where cells need to be expanded or maintained.

Since its introduction in 2011, Bio-Rad Laboratory’s Droplet Digital PCR (ddPCR™) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications. At the second annual CHI Digital PCR Conference in San Diego, CA, Oct. 7–9, 2013, 12 scientists using Bio-Rad’s Droplet Digital PCR systems will highlight ddPCR applications that have advanced their research.










